Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension-Reference-Cited by-同舟云学术

Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension

Published:2009-11-20 Issue:2 Volume:33 Page:118-122
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Tsutamoto Takayoshi,Nishiyama Keizo,Yamaji Masayuki,Kawahara Chiho,Fujii Masanori,Yamamoto Takashi,Horie Minoru

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/hr2009192.pdf

Reference30 articles.

1. Grossman E, Peleg E, Carroll J, Shamiss A, Rosenthal T . Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension. Am J Hypertens 1994; 7: 1041–1044.

2. Bauer IH, Reams GP, Wu Z, Lau-Sieckman A . Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension. J Hum Hypertens 1995; 9: 237–243.

3. Gavras I, Gavras H . Effects of eprosartan vs. enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study Eprosartan Multinational Study Group. Curr Med Res Opin 1999; 15: 15–24.

4. Ichikawa S, Takayama Y . Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients. Hypertens Res 2001; 24: 641–646.

5. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S . A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res 2000; 87: E1–E9.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aldosterone breakthrough from a pharmacological perspective;Hypertension Research;2022-04-14

2. Are the Newest Angiotensin Receptor Blockers Preferred than the Old Members in COVID-19 Patients with Cardiovascular Comorbidity?;International Journal of Pharmacology;2021-07-15

3. Effects of Angiotensin II Receptor Blockers on Ventricular Hypertrophy in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials;Cardiovascular Drugs and Therapy;2021-01-06

4. High-dose nitrate therapy recovers the expression of subtypes α1 and β-adrenoceptors and Ang II receptors of the renal cortex in rats with myocardial infarction-induced heart failures;BMC Cardiovascular Disorders;2020-02-27

5. Candesartan modulates microglia activation and polarization via NF-κB signaling pathway;International Journal of Immunopathology and Pharmacology;2020-01